结论：异基因非清髓性外周血干细胞移植可选择性地应用于晚期乳腺癌的治疗。
Conclusion: Allogeneic peripheral blood stem cell non-myeloablative transplantation can be selectively used in the treatment of metastasis breast cancer.
多因素分析提示，清髓性预处理、巨细胞病毒感染是移植后出血性膀胱炎发生的相关因素。
Myeloablative regiment and cytomegalovirus infection were the main risk factors of HC, indicated by multiplicity analysis.
应用推荐